Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

Structure-Activity Relationships and Drug Design01:28

Structure-Activity Relationships and Drug Design

469
Drug design is a dynamic field that involves discovering and developing new medications based on specific biological targets. This process heavily relies on structure-activity relationships (SAR) and quantitative structure-activity relationships (QSAR) to guide the design and optimization of efficient drugs.
SAR studies the intricate relationship between a drug's chemical structure and biological activity. It focuses on understanding how modifications to a drug's structure can influence...
469
Aryldiazonium Salts to Azo Dyes: Diazo Coupling01:11

Aryldiazonium Salts to Azo Dyes: Diazo Coupling

2.9K
The reaction of weakly electrophilic aryldiazonium (also called arenediazonium) salts with highly activated aromatic compounds leads to the formation of products with an —N=N— link, called an azo linkage. This reaction, presented in Figure 1, is known as diazo coupling and occurs without the loss of the nitrogen atoms of the aryldiazonium salt. Highly activated aromatic compounds such as phenols or arylamines favor the diazo coupling reaction. The coupling generally occurs at the...
2.9K
Combined Effects of Drugs: Synergism01:27

Combined Effects of Drugs: Synergism

3.7K
Synergism is a useful mechanism where combining two or more drugs is more effective than each constituent used alone. Such combinations are also called supra-additive interactions. The drugs collectively enhance the final therapeutic effect by acting on different targets. Another advantage is that the low dose of each constituent drug is sufficient to achieve the desired effect. This helps reduce the duration of therapy and lower the adverse effects of these drugs.
Such synergistic combinations...
3.7K

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

CoMn<sub>2</sub>O<sub>4</sub>/Co(OH)<sub>2</sub> anchored on a MoS<sub>2</sub>/MWCNT scaffold: a robust electrocatalyst for low overpotential and high current density water electrolysis.

Nanoscale·2026
Same author

The Development of Chemical Probes for Targeting Coactivator Associated Arginine Methyltransferase 1 (CARM1) Inhibitors.

Drug development research·2026
Same author

A Retrospective Study of Outcomes of Surgical Management of Severe Laryngomalacia.

Cureus·2026
Same author

Pediatric Tracheostomy: A Five-year Retrospective Review at a Tertiary Care Center.

Turkish archives of otorhinolaryngology·2026
Same author

Azole Amide Analogues as Antibacterial Agents Against Methicillin-Resistant Staphylococcus aureus and Its Structure-Activity Relationship Studies.

Drug development research·2026
Same author

A hierarchical BCN-MoS<sub>2</sub> nanocomposite for the electrochemical hydrogen evolution reaction in natural seawater: comparative studies across various electrolytes.

Nanoscale·2026

Related Experiment Video

Updated: May 20, 2025

Microwave-Assisted Preparation of 1-Aryl-1H-pyrazole-5-amines
05:07

Microwave-Assisted Preparation of 1-Aryl-1H-pyrazole-5-amines

Published on: June 23, 2019

6.6K

Pyrazoles: A Master Key to Tackle Multidrug-Resistant Acinetobacter baumannii and Its Structure Activity Relationship

Saraswati Sharma1, Sahana Raju2, Santosh Kumar Verma3

  • 1Faculty of Science and Technology, The ICFAI University Raipur, Durg, Chhattisgarh, India.

Chemical Biology & Drug Design
|March 24, 2025
PubMed
Summary
This summary is machine-generated.

New pyrazole derivatives show promise as novel antibiotics against multidrug-resistant Acinetobacter baumannii. This research highlights pyrazole compounds as a potential solution to combat challenging Gram-negative bacterial infections.

Keywords:
Acinetobacter baumanniiGram‐negativePyrazoleSARdrug discovery

More Related Videos

Author Spotlight: Advancing Antibiotic Resistance Research Using an Efflux&#45;Deficient Bacterial Strain and a Single&#45;Copy Gene Expression System
05:06

Author Spotlight: Advancing Antibiotic Resistance Research Using an Efflux-Deficient Bacterial Strain and a Single-Copy Gene Expression System

Published on: January 5, 2024

500
Development of a Polymicrobial Colony Biofilm Model to Test Antimicrobials in Cystic Fibrosis
07:16

Development of a Polymicrobial Colony Biofilm Model to Test Antimicrobials in Cystic Fibrosis

Published on: September 20, 2024

821

Related Experiment Videos

Last Updated: May 20, 2025

Microwave-Assisted Preparation of 1-Aryl-1H-pyrazole-5-amines
05:07

Microwave-Assisted Preparation of 1-Aryl-1H-pyrazole-5-amines

Published on: June 23, 2019

6.6K
Author Spotlight: Advancing Antibiotic Resistance Research Using an Efflux&#45;Deficient Bacterial Strain and a Single&#45;Copy Gene Expression System
05:06

Author Spotlight: Advancing Antibiotic Resistance Research Using an Efflux-Deficient Bacterial Strain and a Single-Copy Gene Expression System

Published on: January 5, 2024

500
Development of a Polymicrobial Colony Biofilm Model to Test Antimicrobials in Cystic Fibrosis
07:16

Development of a Polymicrobial Colony Biofilm Model to Test Antimicrobials in Cystic Fibrosis

Published on: September 20, 2024

821

Area of Science:

  • Medicinal Chemistry
  • Microbiology
  • Drug Discovery

Background:

  • Gram-negative bacteria, particularly the ESKAPE group, present significant treatment challenges due to resistance mechanisms.
  • Acinetobacter baumannii is a major cause of hospital- and community-acquired infections, with limited new antibiotic options developed in 50 years.
  • The emergence of multidrug-resistant (MDR) strains necessitates the urgent development of novel antibacterial agents.

Purpose of the Study:

  • To review recent advancements in pyrazole-containing derivatives for antibacterial applications.
  • To evaluate the efficacy of pyrazole derivatives against multidrug-resistant Acinetobacter baumannii.
  • To explore the structure-activity relationships (SAR) of pyrazole derivatives for targeted drug design.

Main Methods:

  • Literature review of pyrazole derivatives with antibacterial activity reported in the last decade.
  • Analysis of studies focusing on pyrazole derivatives against Gram-negative bacteria, especially Acinetobacter baumannii.
  • Examination of structure-activity relationship data for pyrazole-based compounds.

Main Results:

  • Pyrazole derivatives exhibit broad-spectrum antibacterial activity against various bacterial strains.
  • Several pyrazole derivatives demonstrate significant efficacy against multidrug-resistant Acinetobacter baumannii.
  • Structure-activity relationship studies provide insights into key features for enhanced antibacterial potency.

Conclusions:

  • Pyrazole-containing compounds represent a promising scaffold for developing new antibiotics.
  • Further research into pyrazole derivatives could lead to effective treatments for Acinetobacter baumannii infections.
  • This review serves as a foundation for designing novel pyrazole-based small molecules to combat MDR Gram-negative infections.